GREENVILLE, S.C.--(BUSINESS WIRE)--Glytec, a clinical information technology company solely dedicated to the mission of improving insulin management and glycemic control, is pleased to share the results of a late-breaking poster that was presented at the American Association of Clinical Endocrinologists (AACE) 23rd Annual Scientific and Clinical Congress. The poster, “New Interfaces for eGlycemic Management System Saves Nursing Time and Improves Patient Outcomes: Time and Motion Nursing Study,” is based on a study that shows a reduction in nursing time and improvements in both patient outcomes and nurse satisfaction through the integration of Glytec’s eGlycemic Management System™ (eGMS™). The study was conducted at West Tennessee Healthcare, a 635-bed tertiary care hospital in rural West Tennessee. The poster was presented by Melanie Mabrey, DNP, ACNP-BC, assistant professor at the Duke University Schools of Nursing and Medicine, during the Congress’s general poster session.
With CMS’ Surgical Care Improvement Project item SCIP-Inf-4, patient safety and length-of -stay implications, hospitals continue to place emphasis on glycemic management. IV insulin therapy can place time stress on nursing staff managing glucose tests, IV drip rate changes, and documentation. Researchers studied the effect that a deeper integration (ADT, LIS, Cerner feeds) of eGlycemic Management System Glucommander™ (GM) by Glytec has on: nursing time, patient glycemic outcomes, and nursing satisfaction.
When compared to a non-integrated IV insulin management dosing tool, nurses using the fully integrated eGMS saved an average of more than three minutes per patient when starting an IV infusion. Total nursing time in post-cardiac, critical care and surgical care was reduced by up to 72 minutes per nurse per patient. Additionally, rates of hypoglycemia and hyperglycemia were decreased through the use of the eGMS. West Tennessee Healthcare exceeded national benchmarks for hypoglycemic results through the use of the eGMS with a 0.06 percent incidence of hypoglycemia (blood glucose <40mg/dl) and achieved 94 percent rate of patients with blood glucose within the target range (70-180 mg/dl). Nurses reported 90-100 percent satisfaction with the system, finding the electronic medical record (EMR) integration easy to use and less likely to have insulin/math errors. In addition, they experienced decreased need for physician calls and a decreased shift workload.
“Nurses are the front line of hospital care delivery and are an essential resource in operational efficiency and quality patient care. Maximizing their effectiveness is critical to safe patient care. Evidence demonstrates decreasing nursing workload is associated with better patient outcomes. So, initiatives like the eGlycemic Management System that can help decrease workload while improving outcomes and nursing satisfaction can have a tremendous impact for a hospital,” says Mabrey, lead author of the poster.
“Managing inpatient blood glucose remains a challenge for hospitals and health systems across the U.S. and can be very time consuming for nursing staff,” says Johna Burks, RN from West Tennessee Healthcare. “Our findings show that not only does Glytec’s fully integrated eGMS reduce rates of hyperglycemia and hypoglycemia throughout the enterprise, but that time spent by nurses monitoring and treating patients with these conditions can be drastically reduced. Any organization not utilizing such a system to ensure efficiency and accuracy of blood glucose management is not providing the highest standard of care.”
The Glytec eGlycemic Management System is a comprehensive, integrated glycemic management and surveillance system. Glytec has the only FDA-cleared algorithms for IV, subcutaneous and pediatric insulin dosing. The cloud-based system seamlessly integrates with leading EMRs and includes advanced clinical and business intelligence analytics and real-time surveillance capabilities.
“AACE is an important venue for critical discussion of the issues of insulin management and glycemic control, and we’re pleased that these findings were presented at this year’s Congress,” says Laurel Fuqua, RN, MSN, Chief Clinical Innovation Officer of Glytec. “These findings illustrate that solutions like our eGlycemic Management System which integrate with an entire HIS not only transform hospital glycemic management, but also seamlessly support nurses in their direct care of patients and benefit the efficiency of their work. We’ve worked hard to ensure our clients achieve significant results through the use of the eGMS, and we’re dedicated to providing the solutions that healthcare organizations need to deliver top-notch care to patients at risk for abnormal blood glucose levels.”
A diverse community of scholars and clinicians, Duke University School of Nursing is educating the next generation of transformational leaders in nursing. We advance nursing science in issues of global importance and foster the scholarly practice of nursing. In 2011, U.S. News and World Report ranked Duke among the top seven graduate schools of nursing in the nation. Duke University School of Nursing is also ranked 11th in National Institutes of Health awards among U.S. schools of nursing. The School offers masters, PhD and doctor of nursing practice degrees, as well as an accelerated bachelor of science in nursing degree to students who have previously graduated from college.
About West Tennessee Healthcare
West Tennessee Healthcare is an 806-bed public, not-for-profit healthcare system located in Jackson, Tennessee. Its mission is to improve the health and well-being of the communities it serves while providing exceptional and compassionate care. It serves 18 West Tennessee Counties with 4 hospitals and a wide range of outpatient diagnostic and treatment services. Jackson Madison County General Hospital, founded in 1950, is the flagship of West Tennessee Healthcare.
Founded in 2006, Glytec is a rapidly growing clinical information technology company solely dedicated to the mission of improving insulin management and glycemic control. The eGlycemic Management System™ (eGMS™) enables hospitals and healthcare systems to significantly reduce the frequency, risks and costs of hyperglycemia and hypoglycemia and offer superior care to their diabetic and surgical patients. Glytec’s solution has evolved dramatically over its eight year history; from the very first of its kind, computerized IV insulin dosing tool to the first and only comprehensive, integrated glycemic management and surveillance system. The eGMS includes the only suite of FDA- cleared, computerized, predictive dosing algorithms for IV, subcutaneous and pediatric dosing: Glucommander IV™ (FDA clearance 2006), Glucommander SubQ™ (FDA clearance 2010) and Glucommander Pediatrics™ (FDA clearance 2012). The unique breadth and depth of the Glucommander Suite™ allows hospitals to standardize its approach across all areas of the hospital.